Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

US Patent 9072748 · Granted Jul 7, 2015

Estimated economic value: $112,787,000

Assignee

Inventors

View full patent text on Google Patents →